Guardian Pharmacy Services (NYSE:GRDN) Hits New 1-Year High – Here’s Why

Guardian Pharmacy Services, Inc. (NYSE:GRDN) shares hit a new 52-week high during trading on Tuesday. The company traded as high as $48.77 and last traded at $48.31, with a volume of 275,237 shares traded. The stock had previously closed at $47.02.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the stock. Weiss Ratings cut shares of Guardian Pharmacy Services from a “buy (b)” rating to a “buy (b-)” rating in a research note on Friday, October 23rd. Truist Financial lifted their target price on Guardian Pharmacy Services from $47.00 to $51.00 and gave the company a “buy” rating in a research note on Monday, September 21st. KeyCorp assumed coverage on Guardian Pharmacy Services in a research note on Tuesday, September 22nd. They issued an “overweight” rating and a $52.00 price target for the company. Wall Street Zen downgraded Guardian Pharmacy Services from a “buy” rating to a “hold” rating in a research note on Sunday, October 25th. Finally, Oppenheimer increased their price objective on shares of Guardian Pharmacy Services from $43.00 to $49.00 and gave the company an “outperform” rating in a report on Friday, August 7th. Nine analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, Guardian Pharmacy Services currently has a consensus rating of “Moderate Buy” and a consensus target price of $45.57.

Guardian Pharmacy Services Stock Performance

The firm has a market capitalization of $2.42 billion, a P/E ratio of 41.21, a P/E/G ratio of 2.20 and a beta of 0.06. The stock’s 50 day simple moving average is $41.61 and its 200 day simple moving average is $38.39.

Guardian Pharmacy Services (NYSE:GRDN) last released its quarterly earnings data on Thursday, November 5th. The company reported $0.33 earnings per share for the quarter, topping analysts’ consensus estimates of $0.31 by $0.02. The company had revenue of $371.07 million during the quarter, compared to analyst estimates of $365.76 million. Guardian Pharmacy Services had a net margin of 4.50% and a return on equity of 29.97%. On average, analysts anticipate that Guardian Pharmacy Services, Inc. will post 1.18 earnings per share for the current year.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. First Trust Advisors LP purchased a new stake in shares of Guardian Pharmacy Services during the 1st quarter valued at $3,528,000. Dimensional Fund Advisors LP boosted its holdings in shares of Guardian Pharmacy Services by 200.0% in the 1st quarter. Dimensional Fund Advisors LP now owns 208,594 shares of the company’s stock valued at $7,855,000 after acquiring an additional 139,070 shares during the last quarter. Globeflex Capital L P purchased a new position in shares of Guardian Pharmacy Services during the 2nd quarter valued at about $1,857,000. Bank of America Corp DE lifted its holdings in Guardian Pharmacy Services by 86.1% in the first quarter. Bank of America Corp DE now owns 128,048 shares of the company’s stock valued at $4,822,000 after acquiring an additional 59,245 shares during the period. Finally, Sanctuary Advisors LLC acquired a new stake in Guardian Pharmacy Services during the first quarter valued at $1,352,000.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc. provides pharmacy services to people living in long-term care and residential care settings. Its customers include assisted living and skilled nursing communities, behavioral health facilities, and other group-living providers. The company supplies prescription medications and offers medication packaging, delivery, consulting, and clinical support. Its services are designed to help care providers manage residents’ medication needs and support continuity of care. Founded in 2004, Guardian operates a network of pharmacies serving communities across the United States.